Cognition Therapeutics CGTX
NASDAQ CGTX
$0.67 -0.02 (-2.90%)
At close: Nov 10, 2026 · 4:00 PM EST

Cognition Therapeutics (CGTX) Preferred Stock Liabilities (2020 - 2021)

Updated

Cognition Therapeutics (CGTX) recorded Preferred Stock Liabilities of $84.76 million in Q3 2021, up 53.1% from $55.37 million a year earlier and unchanged from the prior quarter.

Analysis

Cognition Therapeutics (CGTX) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends

At the end of FY2020, Cognition Therapeutics reported Preferred Stock Liabilities of $55.37 million.

  • Per Business Quant, the preceding three quarters came in at $84.76 million (Q2 2021), $55.37 million (Q1 2021) and $55.37 million (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Cognition Therapeutics 63.72 Mn -68.99 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 84.76 Mn
Jun 30, 2021 84.76 Mn
Mar 31, 2021 55.37 Mn
Dec 31, 2020 55.37 Mn
Sep 30, 2020 55.37 Mn
API Access

Cognition Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=CGTX&period=max&api_key=YOUR_API_KEY